top of page

A Pfizer Manufacturing Video for Hemophilia

Screen Shot 2023-09-04 at 3.09.14 PM.png

In the 1980s, 50% of all hemophilia patients developed AIDs due to poor manufacturing standards.

At the launch of its hemophilia agent, HEMLIBRA, Genentech saw how important it was to help the community feel safe when taking their medication. 

Despite remaining unproduced, Match-Cut was a true passion project, an ode to all workers involved in the manufacturing process, presenting match-cuts from developmental scientists, to production leads, to the delivery personnel at the end of the road. 

bottom of page